Utah Medical Products Inc (UTMD) returns
Utah Medical Products returns over 10 years
$1,000 invested in Utah Medical Products ten years ago was worth $1,256 at the close on October 30, 2026, with dividends reinvested: an average return of 2.3% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -8.1% | — | $919.31 | -0.9% |
| 3 months | -1.7% | — | $982.60 | +2.1% |
| Year to date | +23.3% | — | $1,233 | +11.7% |
| 1 year | +22.6% | — | $1,226 | +12.4% |
| 3 years | -8.8% | -3.0% | $911.85 | +88.5% |
| 5 years | -22.5% | -5.0% | $775.04 | +76.0% |
| 10 years | +25.6% | +2.3% | $1,256 | +316.6% |
Utah Medical Products return by calendar year
| Year | UTMD | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +23.3% | +11.7% | +11.6% |
| 2025 | -7.0% | +17.7% | -24.7% |
| 2024 | -25.7% | +24.9% | -50.6% |
| 2023 | -15.1% | +26.2% | -41.3% |
| 2022 | +1.8% | -18.2% | +20.0% |
| 2021 | +22.0% | +28.7% | -6.7% |
| 2020 | -20.9% | +18.4% | -39.2% |
| 2019 | +31.4% | +31.2% | +0.2% |
| 2018 | +3.2% | -4.6% | +7.8% |
| 2017 | +13.6% | +21.7% | -8.1% |
| 2016 | +26.3% | +12.0% | +14.3% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: UTMD financials · UTMD valuation
No forecast, no recommendation. This page describes Utah Medical Products Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.